Niacinamide 4% / Tazarotene 0.1%
Product Images NDC 72934-1161

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Niacinamide 4% / Tazarotene 0.1% (NDC 72934-1161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

W (2 End)

FDA Label Image

F (1161 2 Front)

F (1161 2 Front)
This is a prescription medication in gel form containing 4% niacinamide and 0.1% tazarotene, with a net weight of 30 grams. The National Drug Code (NDC) of this medication is 72934-1161-2.*
FDA Label Image

X (1161 2 Middle)

X (1161 2 Middle)
The product is a pharmaceutical with lot number 0113, manufactured by OUOVASTO on January 1, 1970. The active ingredient is Niacinamide USP with a concentration of 0.1%. The other ingredients are inactive, and one of them is Suspendisse Gel in a concentration of 95.9%.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.